Navigation Links
Novel Apolipoprotein A-I Therapy, CSL112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show
Date:11/5/2012

LOS ANGELES, Nov. 5, 2012 /PRNewswire/ -- Infusions of a novel formulation of apolipoprotein A-I (apoA-I) – the main component of high-density lipoprotein (HDL) – rapidly increased the presence of key biomarkers associated with reverse cholesterol transport, a process by which cholesterol is removed from arteries and transported to the liver for clearance, according to data from a Phase 1 study sponsored by CSL Limited. Rapid removal of cholesterol following a heart attack may play a role in stabilizing vulnerable plaque lesions and lowering the high risk of subsequent attacks.

"In our study, CSL112 dramatically elevated measures of cholesterol efflux capacity, a newly recognized marker of HDL function, and rapidly raised blood levels of apoA-I," said Andreas Gille, MD, PhD, CSL Head of Clinical and Translational Science Strategy, and lead study author. "This is a very exciting early finding when viewed in the context of reducing the risk of recurrent heart attacks. We look forward to further developing CSL112 with the goal of meeting a significant unmet medical need in the acute coronary syndrome patient population."

Data from two CSL112 Phase 1 studies presented at the American Heart Association (AHA) meeting demonstrated a positive safety and pharmacokinetic (PK) profile for CSL112, warranting progression to Phase 2 development. CSL112 will be studied for the early reduction of recurrent cardiovascular events in acute coronary syndrome (ACS) patients.

Study Design and Key Findings
Biomarkers of cholesterol movement following infusions of CSL112 were observed in 36 healthy subjects. Three dosing regimens were studied, including 4 once-weekly infusions of 3.4g, 4 once-weekly infusions of 6.8g, and 8 twice-weekly infusions of 3.4g. Subjects were randomized to CSL112 or placebo (3:1, respectively). All biomarker responses were dose dependent and showed similar magnitude and tim
'/>"/>

SOURCE CSL Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novelos Therapeutics Closes $2 Million Private Placement
2. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
3. Global eClinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies: MarketResearchReports.Biz
4. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
5. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
6. Frost & Sullivan Lauds IncellDx for Developing a Novel, Non-invasive Method for Cervical Cancer Testing
7. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market
9. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
10. Strategic Agreement Launches Novel Drug Development Model
11. Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... company with a focus on Omega-3 therapies for ... the Board of Directors approved the granting of ... the close of business on Friday, September 12, ... common shares of the Company were granted in ...
(Date:9/15/2014)... 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers and ... market data on the Spain Aesthetic Lasers and ... millions of US dollars, volume (in units) and ... Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices ... Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- On September 8, 2014, Dr. ... a Citizen Petition to Dr. Margaret Hamburg ... another Black Box Warning to Levaquin, Cipro, and ... a Black Box Warning for the following psychiatric ... or acts, loss of consciousness, delirium, depressed level ...
Breaking Medicine Technology:Pivotal Therapeutics Grants Incentive Stock Options 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3
... Reportlinker.com announces that a new ... its catalogue: Epidemiology: ... risk factor for deep vein thrombosis ... http://www.reportlinker.com/p0536561/Epidemiology-Major-Abdominal-Surgery-–-A-key-risk-factor-for-deep-vein-thrombosis-and-pulmonary-embolism.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ...
... 2011 Zimmer Holdings, Inc. (NYSE and SIX: ZMH), ... will be participating in the Goldman Sachs 32nd Annual ... Palos Verdes, California, on June 7, 2011, at 8:40 ... of the presentation can be accessed via Zimmer,s Investor ...
Cached Medicine Technology:Reportlinker Adds Epidemiology: Major Abdominal Surgery - A key risk factor for deep vein thrombosis and pulmonary embolism 2Zimmer Holdings to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:9/15/2014)... Sept. 15, 2014 (HealthDay News) -- U.S. heart experts ... electrocardiogram (ECG) when evaluating young people for underlying heart ... The American Heart Association and the American College of ... detailed personal and family medical history along with a ... or congenital (existing from birth) risks for sudden cardiac ...
(Date:9/15/2014)... September 12, 2014 - An estimated 8% of ... at some point during their lifetime. Brought on by ... the result of altered chemistry and physiology of the ... brain versus one altered by PTSD is essential to ... Center for BrainHealth at The University of Texas at ...
(Date:9/15/2014)... September 15, 2014 This year, ... founding in 2007. To mark the special occasion, Avenidas ... supporting the village and helping it to get started ... secure and fun community for seniors. Members of Avenidas ... and live in their own homes. They are able ...
(Date:9/15/2014)... Amy Norton HealthDay Reporter ... small number of medications are responsible for sending thousands of ... government study finds. Each year between 2007 and 2011, ... after getting a hold of family members, medication, according to ... "Three-quarters of those children were just 1 or 2 years ...
(Date:9/15/2014)... 15, 2014 Array Health ... technology, today announced that Independence Blue Cross ... southeastern Pennsylvania, has selected the Array Spectrum™ Private ... exchange marketplace for employers with more than 100 ... Spectrum™, Independence will offer employer groups a comprehensive ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:EEG study findings reveal how fear is processed in the brain 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 3Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3
... comes to chronic disease care, study finds , , TUESDAY, ... factor driving soaring rates of chronic disease in the ... their European counterparts, a new study finds. , It,s ... such as diabetes and heart disease account for some ...
... October 1, 2007 -- According to a study conducted ... lesbian, gay, and bisexual populations, blacks and Latinos do ... on the theory that stress related to prejudice would ... black lesbians, gay men, and bisexuals face prejudice related ...
... treatments can be the worst news a cancer patient ... of Missouri-Columbia is working steadfastly to learn why some ... drug cisplatin, in hopes of identifying the particular genes ... as possible. , In a paper published in the ...
... The first significant genetic finding in premenstrual dysphoric ... a very severe form of the more commonly known ... 5-8% of women, and is associated with severe emotional ... anger, headaches, weight gain and more, to such an ...
... When an adult suffers a cardiorespiratory arrest the rapid ... avoid sudden death in many cases. Nevertheless, defibrillation also ... that passes from the moment of the attack, the ... in order to avoid avoidable deaths, more and more ...
... N.J., Oct. 2 MedQuist Inc.,(Pink Sheets: ... multi-year agreement,with MedAssets Supply Chain Systems, one ... the relationship with MedAssets and,allowing them to ... speech,recognition and clinical documentation solutions. As ...
Cached Medicine News:Health News:Obesity Driving Rising U.S. Health Costs 2Health News:Obesity Driving Rising U.S. Health Costs 3Health News:Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study 2Health News:MU researchers studying model to learn why certain cancers become resistant to drugs 2Health News:First significant genetic finding in severe PMS, or PMDD 2Health News:Algorithms to reanimate the heart 2Health News:Algorithms to reanimate the heart 3Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 2Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 3
Acuvue Toric is an exceptionally comfortable soft contact lens made especially for people with astigmatism. The Acuvue Toric lens is designed to comfortably fit the unique shape of your eye....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Easyloupes are exceptional optics that you have come to expect from Oculus. Available in either 1.8x or 2.5x magnification and 40 cm working distance (15.75 inches), they have the well-known durabili...
... designed for computer operators who require ... placed at different heights and distanced ... Card is printed two sided- black ... and uses two type sizes to ...
Medicine Products: